tiprankstipranks
Trending News
More News >
Veru (VERU)
NASDAQ:VERU
US Market
Advertisement

Veru (VERU) Stock Forecast & Price Target

Compare
1,984 Followers
See the Price Targets and Ratings of:

VERU Financial Forecast

VERU Earnings Forecast

The previous quarter’s earnings for VERU were -$0.50.
The previous quarter’s earnings for VERU were -$0.50.

VERU Sales Forecast

The previous quarter’s earnings for VERU were $0.00.
The previous quarter’s earnings for VERU were $0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Oppenheimer Analyst forecast on VERU
Oppenheimer
Oppenheimer
$40$25
Buy
924.59%
Upside
Reiterated
08/13/25
Oppenheimer Sticks to Its Buy Rating for Veru (VERU)
Raymond James Analyst forecast on VERU
Raymond James
Raymond James
$30$20
Buy
719.67%
Upside
Reiterated
08/13/25
Raymond James Keeps Their Buy Rating on Veru (VERU)Raymond James analyst Gary Nachman lowered the price target on Veru, Inc. (NASDAQ: VERU) to $20.00 (from $30.00) while maintaining a Outperform rating.
B. Riley Securities Analyst forecast on VERU
B. Riley Securities
B. Riley Securities
$50
Buy
1949.18%
Upside
Reiterated
02/11/25
We reiterate our Buy rating on Veru (VERU, $5 PT)
H.C. Wainwright Analyst forecast on VERU
H.C. Wainwright
H.C. Wainwright
$30
Buy
1129.51%
Upside
Reiterated
01/02/25
Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (NASDAQ: CRVS) and Veru (NASDAQ: VERU)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Oppenheimer Analyst forecast on VERU
Oppenheimer
Oppenheimer
$40$25
Buy
924.59%
Upside
Reiterated
08/13/25
Oppenheimer Sticks to Its Buy Rating for Veru (VERU)
Raymond James Analyst forecast on VERU
Raymond James
Raymond James
$30$20
Buy
719.67%
Upside
Reiterated
08/13/25
Raymond James Keeps Their Buy Rating on Veru (VERU)Raymond James analyst Gary Nachman lowered the price target on Veru, Inc. (NASDAQ: VERU) to $20.00 (from $30.00) while maintaining a Outperform rating.
B. Riley Securities Analyst forecast on VERU
B. Riley Securities
B. Riley Securities
$50
Buy
1949.18%
Upside
Reiterated
02/11/25
We reiterate our Buy rating on Veru (VERU, $5 PT)
H.C. Wainwright Analyst forecast on VERU
H.C. Wainwright
H.C. Wainwright
$30
Buy
1129.51%
Upside
Reiterated
01/02/25
Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (NASDAQ: CRVS) and Veru (NASDAQ: VERU)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Veru

1 Month
xxx
Success Rate
9/31 ratings generated profit
29%
Average Return
-8.70%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 29.03% of your transactions generating a profit, with an average return of -8.70% per trade.
3 Months
xxx
Success Rate
11/31 ratings generated profit
35%
Average Return
+4.32%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 35.48% of your transactions generating a profit, with an average return of +4.32% per trade.
1 Year
Leland GershellOppenheimer
Success Rate
8/31 ratings generated profit
26%
Average Return
-24.26%
reiterated a buy rating 4 months ago
Copying Leland Gershell's trades and holding each position for 1 Year would result in 25.81% of your transactions generating a profit, with an average return of -24.26% per trade.
2 Years
xxx
Success Rate
3/31 ratings generated profit
10%
Average Return
-36.37%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 9.68% of your transactions generating a profit, with an average return of -36.37% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VERU Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Oct 25
Nov 25
Strong Buy
0
0
2
2
2
Buy
0
0
0
0
0
Hold
7
12
12
13
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
12
14
15
9
In the current month, VERU has received 2 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. VERU average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

VERU Stock Forecast FAQ

What is VERU’s average 12-month price target, according to analysts?
Currently, no data Available
What is VERU’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for VERU, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is VERU a Buy, Sell or Hold?
      Currently, no data Available
      What is Veru’s price target?
      Currently, no data Available
      What do analysts say about Veru?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of VERU?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis